Kovack Advisors’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-42,000
| Closed | -$123K | – | 590 |
|
|
2023
Q3 | $123K | Buy |
42,000
+2,000
| +5% | +$5.86K | 0.02% | 522 |
|
|
2023
Q2 | $114K | Buy |
40,000
+5,000
| +14% | +$14.3K | 0.01% | 548 |
|
|
2023
Q1 | $108K | Buy |
35,000
+10,000
| +40% | +$30.9K | 0.01% | 553 |
|
|
2022
Q4 | $52.8K | Buy |
+25,000
| New | +$52.8K | 0.01% | 530 |
|
|
2022
Q2 | – | Sell |
-31,500
| Closed | -$222K | – | 640 |
|
|
2022
Q1 | $222K | Buy |
+31,500
| New | +$222K | 0.02% | 623 |
|